BK Polyomavirus-Associated Urothelial Carcinoma of the Bladder with a Background of BK Polyomavirus Nephropathy in a Kidney Transplant Recipient
Nephron · 2023
DOI: 10.1159/000531822 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nephron, 2023. Verfasst von Sari Iwasaki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Sapporo City General Hospital, Sapporo, Japan. Hauptthemen laut MEDLINE: Kidney Transplantation, Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, BK Virus. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Renal transplant recipients are at increased risk for the development of a malignant neoplasm. Polyomavirus-associated urothelial carcinoma is a rare tumor that occurs in renal transplant recipients, with approximately 41 cases reported since 2002. It accounts for 27–31% of all post-transplant urothelial carcinomas and develops at an average of 8.5 years after transplantation. Histologically, it shows high-grade urothelial carcinoma (95.1%) with a high frequency of glandular differentiation and micropapillary structures (58.5%) and positive immunohistochemistry for polyomavirus large T antigen, p53 (92.9%), and p16 (100%). We encountered a case of BK polyomavirus (BKPyV)-associated urothelial carcinoma of the bladder diagnosed 54 months after kidney transplantation. Histologically, it was a high-grade urothelial carcinoma with micropapillary features, and immunohistochemically, it was diffusely positive for polyomavirus large T antigen, p16, and p53. BKPyV DNA and mRNA for BKPyV large T antigen have been identified in tissues using real-time polymerase chain reaction. The same sequence of the BKPyV VP1 genome hypervariable region was detected in both transplanted kidney tissue with polyomavirus nephropathy and urothelial carcinoma tissue, suggesting that polyomavirus-associated urothelial carcinoma developed in a background of persistent polyomavirus nephropathy. This case showed typical histological features and was detected and treated at an earlier stage than has been reported. It is important to keep in mind that polyomavirus-associated urothelial carcinoma can develop early after transplantation and might be associated with polyomavirus nephropathy. Because of its rapidly progressive nature, careful follow-up with urine cytology and cystoscopy is necessary. We report this case with a literature review.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Sapporo City General Hospital, Sapporo, Japan.
- Department of Pathology, National Institute of Infectious Disease, Tokyo, Japan.
- Department of Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan.
Zitieren
APA
Iwasaki, S., Takahashi, K., Katano, H., Suzuki, T., Sasaki, H., Harada, H., Takada, Y., Makita, K., Fukasawa, Y., & Tsuji, T. (2023). BK Polyomavirus-Associated Urothelial Carcinoma of the Bladder with a Background of BK Polyomavirus Nephropathy in a Kidney Transplant Recipient. Nephron. https://doi.org/10.1159/000531822
Vancouver
Iwasaki S, Takahashi K, Katano H, Suzuki T, Sasaki H, Harada H, et al. BK Polyomavirus-Associated Urothelial Carcinoma of the Bladder with a Background of BK Polyomavirus Nephropathy in a Kidney Transplant Recipient. Nephron. 2023. doi:10.1159/000531822
BibTeX
@article{Iwasaki2023,
author = {Iwasaki, Sari and Takahashi, Kenta and Katano, Harutaka and Suzuki, Tadaki and Sasaki, Hajime and Harada, Hiroshi and Takada, Yusuke and Makita, Keishi and Fukasawa, Yuichiro and Tsuji, Takahiro},
title = {BK Polyomavirus-Associated Urothelial Carcinoma of the Bladder with a Background of BK Polyomavirus Nephropathy in a Kidney Transplant Recipient},
journal = {Nephron},
year = {2023},
doi = {10.1159/000531822}
}
EUVIMED